FDA Inspection 1209240 — Mark D. Epstein, M.D.

Mark D. Epstein, M.D. — FEI 3015925464

The FDA completed an inspection of Mark D. Epstein, M.D. on June 28, 2023 in Hauppauge, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 28, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Hauppauge, NY (United States)

Additional Details

Clinical Investigator (CI)